Joseph Ciaffoni Net Worth & Insider Trades

Joseph Ciaffoni - President and CEO, Collegium Pharmaceutical, Inc

As of June 2, 2023

What is Joseph Ciaffoni's Net Worth?

The current estimated net worth of Collegium Pharmaceutical, Inc's President and CEO, Joseph Ciaffoni, is estimated to be about $19.33M . Joseph Ciaffoni owns about 275,000 units of Collegium Pharmaceutical, Inc common stock. In the last 6 years at Collegium Pharmaceutical, Inc, Joseph Ciaffoni has sold an estimated value of $20.14M worth.

What is Joseph Ciaffoni's Past Insider Trading?

Joseph Ciaffoni's largest purchase order was 76,653 units , worth over $1.22M on December 5, 2022. Joseph Ciaffoni's largest sale order was 115,107 units , worth over $3.08M on February 14, 2023. In total, Joseph Ciaffoni has made about 39 transactions over 6 years of their time at Collegium Pharmaceutical, Inc. Joseph Ciaffoni usually trades in June, with the busiest year in 2022. The most recent transaction was a sale order of 62,544 units , worth over $1.37M on June 2, 2023.

Joseph Ciaffoni

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Joseph Ciaffoni's' Mailing Address?

  • Mailing address is 100 Technology Center Drive Stoughton MA 02072 MA

What are Collegium Pharmaceutical, Inc's Past Insider Trades?

Collegium Pharmaceutical, Inc's most recent insider trade came on June 2, 2023 by Joseph Ciaffoni who sold 62,544 units worth $1.37M . In the last 8 years, insiders at Collegium Pharmaceutical, Inc have sold an estimated value of $92.73M and bought an estimated value of $24.01M worth of shares. Insider trading is most common in May, with the busiest year in 2019. The most active traders at the company are Michael T. Heffernan, Director,  Joseph Ciaffoni, President and CEO,  and Alison B Fleming, EVP & Chief Technical Officer .

COLLEGIUM PHARMACEUTICAL, INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...